Procoagulant and inflammatory response of virus-infected monocytes

European Journal of Clinical Investigation

Volumn 32, Issue 10, 2002, Pages 759-766

  Bouwman, J J M ^a,d   Visseren, F L J ^b   Bosch, M C ^a,d   Bouter, K P ^c,d   Diepersloot, R J A ^a,d  

^a Diakonessen Hospital Utrecht   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c JEROEN BOSCH HOSPITAL   (Netherlands)

^d DEPARTMENT OF SURGERY   (Netherlands)

Author keywords

Chlamydia pneumoniae; Cytomegalovirus; Influenza A virus; Interleukins; Monocytes; Tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR 7; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; PROCOAGULANT; THROMBOPLASTIN;

ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING TIME; CELL ISOLATION; CELL SELECTION; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INFLAMMATION; INFLUENZA VIRUS A; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INFECTION;

ANTIBODIES; CHLAMYDOPHILA INFECTIONS; CORONARY ARTERIOSCLEROSIS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; MONOCYTES; THROMBOPLASTIN; VIRUS DISEASES; WHOLE BLOOD COAGULATION TIME;

EID: 0036428701     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.01041.x     Document Type: Article

References (66)

1. Ross R. The pathogenesis of atherosclerosis; a perspective for the 1990s. Nature 1993;362:801-9.
2. Whicher J, Biasucci L, Rifai N. Inflammation, the acute phase response and atherosclerosis. Clin Chem Lab Ned 1999;37 (5):495-503.
3. Buja LM. Does atherosclerosis have an infectious etiology? Circulation 1996;94:872.
4. Morré SA, Stooker W, Lagrand WK, van de Brule AJC, Niessen HWM. Microorganisms in the etiology of atherosclerosis. J Clin Pathol 2000;53:647-54.
5. Ross R. Atherosclerosis, an inflammatory disease. N Engl J Med 1999;340 (2):115-26.
6. Friedman HM, Macarak EJ, MacGregor RR, Wolfe J, Kefalides NA. Virus infection of endothelial cells. J Infect Dis 1981;143 (2):266-73.
7. Minick CR, Fabricant CG, Fabricant J, Litrenta MM. Atheroarteriosclerosis induced by infection with a herpes virus. Am J Pathol 1979;96:673-706.
8. Campbell AE, Loria RN, Madge GE. Coxsackie virus B cardiopathy and angiopathy in the hypercholesteremic host. Atherosclerosis 1978;31:295-306.
9. Burch GE, Tsui CY, Harb JM. Pathologic changes of aorta and coronary arteries of mice infected with Coxsackie B virus. Proc Soc Exp Biol Medl 1971;137:657-61.
10. Burch GE, Harb JM, Hiramoto Y, Shewey L. Viral infection of the aorta of man associated with early atherosclerotic changes. Am Heart J 1973;86:523-34.
11. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis; an assessment of the evidence and the need for future research. Circulation 1997;96:4095-103.
12. Mosorin et al. Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of the carotid artery. Arterioscl Thromb Vasc Biol 2000;20:1061-7.
13. Quinn TC, Gaydos CA. In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells. Am Heart J 1999;138:S507-S511.
14. Saikku P, Leinonen M, Matilla K et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-6.
15. Saikku P, Leinonen M, Tenkanen L et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Intern Med 1992;116:372-8.
16. Zhu J, Shearer GM, Norman JE, Pinto LA, Marincola FM et al. Host response to Cytomegalovirus infection as a determinant of susceptibility to coronary artery disease: Sex based differences in inflammation and type of immune response. Circulation 2000;102 (20):2491-6.
17. Strachan DP, Carrington D, Mendall MA, Butland BK, Sweetnam PM, Elwood PC. Cytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease study. Heart 1999;81 (3):248-51.
18. Ridker PM, Hennekens CH, Buring JE, Kundsin R, Shih J. Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, Herpes simplex virus and Cytomegalovirus and the risk for cardiovascular disease in women. Ann Intern Med 1999;131 (8):573-7.
19. Ridker PM, Hennekens CH, Stampfer MJ, Wang F. Prospective study of herpes simplex virus, Cytomegalovirus and the risk of future myocardial infarction and stroke. Circulation 1998;98 (25):2796-9.
20. Gattone M, Iacoviello L, Colombo M, Castelnuovo AD, Soffiantino F et al. Chlamydia pneumoniae and Cytomegalovirus seropositivity, inflammatory markers and the risk of myocardial infarction at young age. Am Heart J 2001;142 (4):633-40.
21. Zhu J, Quyyumi AA, Norman JE, Csako G, Waclawiw MA, Shearer GM, et al. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol 2000;85 (2):140-6.
22. Visseren FL, Bouter KP, Pon MJ, Hoekstra JB, Erkelens DW, Diepersloot RJ. Patients with diabetes mellitus and atherosclerosis; a role for Cytomegalovirus? Diabetes Res Clin Pract 1997;36 (1):49-55.
23. Blankenberg S, Rupprecht HJ, Bickel C, Espinola-Klein C, Rippin G et al. Cytomegalovirus infection with interleukine 6 response predicts cardiac mortality in patients with coronary artery disease. Circulation 2001;103 (24):2915-21.
24. Muhlestein JB, Horne BD, Carlquist JF, Madsen TE, Blair TL et al. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation 2000;102 (16):1917-23.
25. Zhu J, Quyyumi AA, Norman JE, Csako G, Epstein SE. Cytomegalovirus in the pathogenesis of atherosclerosis: The role of inflammation as reflected by elevated C-reactive protein levels. J Am Coll Cardiol 1999;34 (6):1738-43.
26. Kaftan HA, Kaftan O, Kilic M. Markers of chronic inflammation. Are they important in cases with chronic coronary heart disease? Jpn Heart J 1999;40 (3):275-80.
27. Visseren FLJ, Bouwman JJM, Bouter KP, Diepersloot RJA, de Groot Ph, Erkelens DW. Procoagulant activity of endothelial cells after infection with respiratory viruses. Thromb Haemost 2000;84 (2):319-24.
28. Van Dam-Mieras M, Muller AD, van Hinsbergh V, Mullers W, Bomans P, Bruggeman C. The procoagulant response of Cytomegalovirus infected endothelial cells. Thromb Haemost 1992;68 (3):364-70.
29. Drake TA, Morrissey JH, Edgington TS. Selective expression of tissue factor in human tissues. Am J Pathol 1989;134:1087-97.
30. Rivers RPA, Cattermole HEJ, Wright I. The expression of surface tissue factor apoprotein by blood monocytes in the course of infections in early infancy. Pediatr Res 1992;31 (6):567-73.
31. Thiruvikraman SV, Guha A, Roboz J, Taubman MB, Nemerson F, Fallon JT. In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin labeled factors VIIa and X. Lab Invest 1996;75:451-61.
32. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A 1989;86:2839-45.
33. Colden-Stansfield M, Ratcliffe D, Cramer E, Gallin E. Characterization of influenza virus-induced leukocyte adherence to human umbilical vein endothelial cell monolayers. J Immunol 1993;151:310-21.
34. Span A, van Dam-Mieras Mullers W, Endert J, Muller A, Bruggeman C. The effect of virus infection on the adherence of leucocytes or platelets to endothelial cells. Eur J Clin Invest 1991;21:331-8.
35. Span A, Endert J, van Boven C, Bruggeman C. Virus induced adherence of monocytes to endothelial cells. FEMS Microbiol 1989;47:237-44.
36. Kaukoranta-Tolvanen S, Teppo A, Laitinen K, Saikku P, Linnavuori K, Lainonen M. Growth of Chlamydia pneumoniae in peripheral blood monocytes and induction of a cytokine response. Microb Pathog 1996;21:215-21.
37. Visseren FLJ, Verkerk MS, Bouter KP, Diepersloot RJA, Erkelens DW. Interleukine IL-6 production by endothelial cells after infection with influenza virus and Cytomegalovirus. J Lab Clin Med 1999;134 (6):623-30.
38. Frostegard J, Ulfgren A, Nyberg P, Hedin U, Swedenborg J et al. Cytokine expression in advanced human atherosclerotic plaques: Dominance of pro-inflammatory (Th1) and macrophage stimulating cytokines. Atherosclerosis 1999;145:33-43.
39. Neumann FJ, Ott I, Marx N, Luther T, Kenngott S et al. Effect of human recombinant Interleukin-6 and Interleukin-8 on Monocyte Procoagulant activity. Arteriosclerosis Thromb Vasc Biol 1997;17:3399-405.
40. Mahoney JB, Coombes BK. Chlamydia pneumoniae and atherosclerosis: Does the evidence support a causal or contributory role? FEMS Microbiol Lett 2001;197 (1):1-9.
41. Osterud B. Tissue factor expression by monocytes: Regulation and pathophysiological roles. Review. Blood Coagul Fibrinolysis 1998;9(1):9-14.
42. Carson SD, Johnson DR, Tracy SM. Tissue factor and the extrinsic pathway of coagulation during infection and vascular inflammation. Eur Heart J 1993;14 (K):98-104.
43. Froberg MK, Adams A, Seacotte N, Parker-Thornberg J, Kolattukudy P. Cytomegalovirus infection accelerates inflammation in vascular tissue overexpressing monocyte chemoattractant protein 1. Circ Res 2001;89 (12):1224-30.
44. Denger S, Jahn L, Wende P, Watson L, Gerber SH et al. Expression of chemo attractant protein cDNA in vascular smooth muscle cells: Induction of the synthetic phenotype: A possible clue to SMC differentiation in the process of atherogenesis. Atherosclerosis 1999;144 (1):15-23.
45. Julkunen I, Melen K, Nyqvist M, Pirhonen J, Sareneva T, Matikainen S. Inflammatory responses in influenza A virus infection. Vaccine 2000;19 (Suppl. 1):S32-7.
46. Byrne GI, Kaloyoglu MV. Chlamydia pneumoniae and atherosclerosis: Links to the disease process. Am Heart J 1999;138 (5 Part 2):S488-90.
47. Van Lenten BJ, Wagner AC, Nayak DP, Hama S, Navab M, Fogelman AM. High-density lipoprotein loses its anti inflammatory properties during acute influenza A infection. Circulation 2001;103 (18):2283-8.
48. Kalayoglu MV, Perkins BN, Byrne GI. Chlamydia pneumoniae infected monocytes exhibit increased adherence to human aortic endothelial cells. Microbes Infect 2001;3 (12):963-9.
49. Guetta E, Guetta V, Shibutani T, Epstein SE. Monocytes harboring Cytomegalovirus: Interactions with endothelial cells, smooth muscle cells and oxidized low-density lipoprotein. Possible mechanisms for activating virus delivered by monocytes to sites of vascular injury. Circ Res 1997;81 (1):8-16.
50. Boyum A. Separation of leucocytes from blood and bone marrow. Scand. J Clin Lab Invest Suppl 1968;97:77.
51. Reed LJ, Muench J. A simple method of estimating fifty percent endpoints. Am J Hyg 1938;27:493.
52. Boyum A, Lovhaug D, Tresland L, Nordlie EM. Separation of leucocytes. Improved cell purity by fine adjustments of gradient medium density and osmolality. Scand J Immunol 1991;34 (6):697-712.
53. Stoll HP, Kramer S, Oberhausen E. A new method of preparing monocyte suspensions from human whole blood. Blood Cells 1986;11 (3):421-8.
54. Clemetson KJ, McGregor JL, McEver RP, Jacques YV, Bainton DF et al. Absence of platelet membrane glycoproteins IIb/IIIa from monocytes. J Exp Med 1985;161:972-83.
55. Levene RB, Rabellino EM. Platelet glycoproteins IIb and IIIa associated with blood monocytes are derived from platelets. Blood 1986;67 (1):207-13.
56. Celi A, Pellegrini G, Lorenzet R, De Blasi A, Ready N et al. P selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci U S A 1994;91 (19):8767-71.
57. Perussia B, Jankiewicz J, Trinchieri G. Binding of platelets to human monocytes: A source of artifacts in the study of the specificity of antileukocyte antibodies. J Immunol Meth 1982;50 (3):269-76.
58. Osterud B. Tissue factor expression by monocytes: Regulation and pathophysiological roles. Review. Blood Coagul Fibrinolysis 1998;9 (1):S9-S14.
59. Collins P, Noble K, Reittie J, Hoffbrand K, Pasi K, Young K. Induction of tissue factor expression in human monocyte/endothelium cocultures. Br J Haematol 1995;91:963-70.
60. Shaw R, Clark R. Interleukines and their interactions in inflammation. Handbook of inflammation. Mediators Inflamm 1989;6:245-58.
61. Nain M, Hinder F, Gong JH, Schmidt A, Bender A et al. Tumor necrosis factor-alpha production of influenza A virus-infected macrophages and potentiating effect of lipopolysaccharides. J Immunol 1990;145 (6):1921-8.
62. Lehmann C, Sprenger H, Nain M, Bacher M, Gemsa D. Infection of macrophages by influenza A virus; characteristics of tumor necrosis factor-alpha (TNF-alpha) gene expression. Res Virol 1996;147 (2-3):123-30.
63. Osterud B, Bjorklid E. The tissue factor pathway in disseminated intravascular coagulation. Semin Thromb Hemost 2001;27 (6):605-17.
64. Smith DA, Irving SD, Sheldon J, Cole D, Kaski JC. Serum levels of the anti-inflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 2001;104:746-9.
65. Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F et al. Protective role of interleukine-10 in atherosclerosis. Circ Res 1999;85 (8):e17-24.
66. Pinderski Oslund LJ, Hedrick CC, Olvera T, Hagenbaugh A, Territo M et al. Interleukine-10 blocks atherosclerotic events in vitro and in vivo. Arterioscl Thromb Vasc Biol 1999;19:2847-53.